For general education only. This information does not diagnose a condition or replace medical advice. Your provider will determine which evaluation or treatment is appropriate for you.
How to read this table
This table compares categories of options. It does not rank them, declare a winner, or suggest that any option is right for you. Your provider determines suitability after reviewing your health history, current medicines, labs, and goals. Nothing here replaces that evaluation.
Route changes more than convenience. It changes how much of the medicine reaches the rest of the body, which changes the risks, the instructions, and who it suits.
Approval, off label use, and compounding
FDA approval applies to a specific product, formulation, indication, and population. Off label use means an approved medicine is prescribed outside its approved labeling. A compounded preparation is not FDA approved and has not undergone the same premarket review for safety, effectiveness, and quality.
Topical minoxidil products are approved for female pattern hair loss in specific formulations. Oral minoxidil is approved for a different condition, and its use for hair loss is off label. An ingredient name alone does not establish approval. Ask for the exact product name, formulation, and current labeling of the medicine offered to you, and whether that use is approved, off label, or compounded.
What a useful conversation covers
Ask whether the cause of your thinning has been identified, because shedding, inherited thinning, and scalp conditions are not managed identically. A medicine does not replace a diagnosis.
Ask how progress will be documented, over what period, and what would prompt a change in approach. Sudden, painful, or patchy loss may warrant specialist evaluation rather than waiting.
Side by side
Considerations worth bringing to your provider. This is not a ranking, and it does not mean any option is right for you.
Topical minoxidil
Product details- What it is
- A solution or foam applied to the scalp that may extend the growth phase of hair follicles.
- How it is used
- Applied to the scalp as directed, usually daily. Consistency matters more than quantity.
- Approval and labeling
- Some topical products are approved for female pattern hair loss. Ask which product and strength is being discussed.
- What the evidence supports
- Studied in female pattern hair loss with results that vary between women and take months to show.
- Common considerations
- Scalp irritation or greasiness can occur. Unwanted facial hair may appear if it spreads.
- Often not appropriate when
- You are pregnant or breastfeeding, or the scalp is inflamed or broken.
- Cost and access
- Pricing is shared after your evaluation. Ask what your plan includes, such as consultations, medication, labs, and follow up, and what happens if your plan changes.
Oral minoxidil
Product details- What it is
- A tablet that may support follicle blood flow and the growth phase, taken systemically.
- How it is used
- Taken by mouth as directed by your provider, with attention to how you respond.
- Approval and labeling
- Approved for a different condition. Use for hair loss is off label, and the product is not the same as a topical one.
- What the evidence supports
- Evidence for hair loss comes largely from smaller studies and clinical experience rather than the same labeling review.
- Common considerations
- Unwanted facial or body hair, fluid retention, and changes in heart rate or blood pressure may occur.
- Often not appropriate when
- You are pregnant or breastfeeding, or have heart or blood pressure concerns your provider identifies.
- Cost and access
- Pricing is shared after your evaluation. Ask what your plan includes, such as consultations, medication, labs, and follow up, and what happens if your plan changes.
Questions to bring
- What diagnosis is being treated, and how was it confirmed?
- Is the formulation you are proposing approved for this use, or off label?
- What side effects should I watch for with this route specifically?
- How will we document change, and when would we reconsider?